Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Limited

NURPF
Neuren Pharmaceuticals LimitedUS flagOther OTC
8.36
USD
- -
- -
0.63EPS
13.27P/E
1.07BMarket Cap
Mar 04Next Earn

Neuren Pharmaceuticals Limited (NURPF) Stock Splits

Learn about Neuren Pharmaceuticals Limited's most recent 1-for-20 basis stock split on November 21, 2017. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Neuren Pharmaceuticals Limited's most recent stock split

Split Date: 2017-11-21
Split Ratio: 1:20
Price Before Split: $0.01
Price After Split: N/A

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 20.00 times fewer shares (a 1:20 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Neuren Pharmaceuticals Limited's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2017-11-211:20Yes$0.01N/A
2012-06-2132:29No$132.41$120.00
2007-12-2627:25No$1048.72$971.03

About Neuren Pharmaceuticals Limited

Company overview and industry information

Neuren Pharmaceuticals Limited (NURPF) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Neuren Pharmaceuticals Limited Summary

Last updated: 2/15/2025

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.